What dose of human mixtard 30/70 (insulin) would be suitable for a 70kg patient during discharge, given their current regimen of injection glargine (insulin glargine) at 8 units and total regular insulin (short-acting insulin) at 26 units per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Basal-Bolus to Mixtard 30/70 at Discharge

For a patient on 8 units of glargine and 26 units total regular insulin daily, start Mixtard 30/70 at approximately 17 units twice daily (total 34 units/day), given before breakfast and dinner.

Calculation Rationale

Total Daily Dose Assessment

  • The current regimen provides 34 units total daily insulin (8 units glargine + 26 units regular) 1
  • When converting to premixed insulin, the American Diabetes Association recommends using approximately 80% of the hospital basal dose as a starting point for discharge planning 1
  • For Mixtard 30/70 (70% NPH/30% regular), the total daily dose should be divided into two injections, typically with 2/3 given before breakfast and 1/3 before dinner 1

Mixtard 30/70 Dosing Strategy

  • Initial total daily dose: Start with 34 units/day (matching current total) 1
  • Distribution: Give approximately 22 units before breakfast (65%) and 12 units before dinner (35%) 1
  • Alternative conservative approach: Use 17 units twice daily (total 34 units), which provides a more balanced split and may be safer initially 1

Critical Considerations for Discharge

Patient Selection Appropriateness

  • Premixed insulins like Mixtard 30/70 are appropriate for patients requiring both basal and prandial coverage who prefer fewer injections 1
  • The American Diabetes Association notes that premixed insulin regimens are noninferior to basal-bolus therapy with similar hypoglycemia rates in type 2 diabetes 1
  • However, randomized trials show premixed insulins have significantly increased hypoglycemia rates in hospitalized patients compared to basal-bolus regimens 2

Titration Instructions

  • Increase the morning dose by 2 units every 3 days if pre-dinner glucose is >180 mg/dL 1, 3
  • Increase the evening dose by 2 units every 3 days if fasting glucose is >130 mg/dL 1, 3
  • If hypoglycemia occurs, reduce the corresponding dose by 10-20% immediately 1

Administration Guidelines

Timing and Technique

  • Administer Mixtard 30/70 immediately before breakfast and immediately before dinner (within 15 minutes of eating) 1
  • The 30% regular insulin component requires meal consumption within 30 minutes of injection 4
  • Do not mix Mixtard 30/70 with any other insulin in the same syringe 1

Monitoring Requirements

  • Check fasting blood glucose and pre-dinner glucose daily during initial titration 1, 3
  • Target fasting glucose: 80-130 mg/dL 1
  • Target pre-meal glucose: 90-150 mg/dL 2

Common Pitfalls to Avoid

Dosing Errors

  • Never continue basal-bolus regimen alongside Mixtard 30/70—this causes dangerous insulin stacking 1, 2
  • Avoid giving Mixtard 30/70 at bedtime instead of dinner, as the regular insulin component increases nocturnal hypoglycemia risk 2
  • Do not use correction doses of rapid-acting insulin at bedtime with this regimen 2

Meal Timing Issues

  • Patients must eat regular meals at consistent times—Mixtard 30/70 is inappropriate for those with erratic eating patterns 1
  • Missing meals after Mixtard 30/70 injection significantly increases hypoglycemia risk 1

Alternative Consideration

When Basal-Bolus May Be Preferred

  • If the patient's admission HbA1c was >9%, consider continuing separate basal and prandial insulins rather than switching to premixed 1
  • Patients requiring >0.5 units/kg/day total insulin may achieve better control with continued basal-bolus therapy 1
  • For a 70kg patient, 34 units/day represents 0.49 units/kg/day—near the threshold where basal-bolus offers advantages 1, 2

Foundation Therapy

  • Continue metformin unless contraindicated, even when using Mixtard 30/70 1
  • Discontinue sulfonylureas to prevent hypoglycemia when using premixed insulin 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Prescription Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.